II期卵巢癌的盆腔放疗。

Pelvic irradiation for stage II ovarian carcinoma.

作者信息

Terada K Y, Morley G W, Roberts J A

机构信息

Department of Obstetrics and Gynecology, University of Michigan School of Medicine, Ann Arbor 48105.

出版信息

Gynecol Oncol. 1988 Jan;29(1):26-31. doi: 10.1016/0090-8258(88)90142-4.

DOI:10.1016/0090-8258(88)90142-4

PMID:3338660

Abstract

Over a 20-year period, 34 patients with FIGO stage II ovarian carcinoma were treated with postoperative pelvic irradiation at the University of Michigan. Complications of radiation treatment were minimal. The overall actuarial disease-free 5-year survival was 53%. This was not significantly different for substages IIA, IIB, or IIC. Patients with well-differentiated tumors had a significantly better survival than patients with moderate or poorly differentiated tumors (P less than 0.05). The implications for managing stage II ovarian carcinoma are discussed.

摘要

在20年的时间里，密歇根大学对34例国际妇产科联盟（FIGO）II期卵巢癌患者进行了术后盆腔放疗。放射治疗的并发症很少。总的5年无病精算生存率为53%。IIA、IIB或IIC亚期的生存率无显著差异。高分化肿瘤患者的生存率明显高于中分化或低分化肿瘤患者（P<0.05）。本文讨论了II期卵巢癌治疗的意义。